Breast Cancer: Dual Immunotherapy Achieves 50% Response in TNBC Without Chemotherapy Breast Cancer: Dual Immunotherapy Achieves 50% Response in TNBC...
breast caner
Eribulin Shows Superior Survival Benefit for HER2-Negative Metastatic Breast Cancer Eribulin Shows Superior Survival Benefit for HER2-Negative Metastatic Breast Cancer...
Breast Cancer Exploits Neural Signaling Pathways to Bypass Blood-Brain Barrier and Invade the Brain Breast Cancer Exploits Neural Signaling Pathways...
Daiichi Sankyo/AstraZeneca's Enhertu Shows Positive Results in Phase III DESTINY-Breast06 Clinical Trial Daiichi Sankyo/AstraZeneca's Enhertu Shows Positive Results in Phase...
Ribociclib Combo Reduces Recurrence Risk in Early Breast Cancer Ribociclib Combo Reduces Recurrence Risk in Early Breast Cancer Reduced Risk...
Ribociclib Plus Endocrine Therapy Shows Promise in Early Breast Cancer: A Look at the NATALEE Trial Ribociclib Plus Endocrine Therapy...
Lancet Oncology: European Consensus on Radiotherapy Combined with Novel Drugs for Breast Cancer Lancet Oncology: European Consensus on Radiotherapy Combined...
Treating Breast Cancer with "Androgen Receptor": Endocrine Therapy Resistant Patients Also Benefit! Treating Breast Cancer with "Androgen Receptor": Endocrine Therapy...
HER2-Low-Expressing Breast Cancer: Clinical Characteristics and Prognosis HER2-Low-Expressing Breast Cancer: Clinical Characteristics and Prognosis Clinical Pathological Characteristics and Prognosis of...
Exosomal circEGFR: A Therapeutic Target in Triple Negative Breast Cancer Exosomal circEGFR: A Therapeutic Target in Triple Negative Breast Cancer...
Low Methionine Diet Shows Promise in Eliminating Triple-Negative Breast Cancer Stem Cells Low Methionine Diet Shows Promise in Eliminating Triple-Negative...
Estradiol's Role in Anastrozole Efficacy for Breast Cancer Prevention Estradiol's Role in Anastrozole Efficacy for Breast Cancer Prevention Influence of...
Breakthrough Study: Anastrozole Reduces Breast Cancer Risk by 49% Breakthrough Study: Anastrozole Reduces Breast Cancer Risk by 49% Breast cancer,...
Groundbreaking Immunotherapy Combination Shows 86% 3-Year Survival in Tough-to-Treat Breast Cancer Groundbreaking Immunotherapy Combination Shows 86% 3-Year Survival in Tough-to-Treat...
Characteristics of HER2 Low Protein Expression in Luminal and Triple-Negative Breast Cancer Characteristics of HER2 Low Protein Expression in Luminal...
Vitamin B5 Found to Promote Cancer Growth, Dietary Restriction Inhibits Cancer Progression Vitamin B5 Found to Promote Cancer Growth, Dietary...
Unlocking Immunotherapy's Potential: NKG2A Inhibition Reveals a Vulnerability in Triple-Negative Breast Cancer Unlocking Immunotherapy's Potential: NKG2A Inhibition Reveals a Vulnerability...
CAR-Based Immunotherapy Advances in Breast Cancer CAR-Based Immunotherapy Advances in Breast Cancer Breast cancer is a malignant tumor with high...
Contrasting Immune Effects of Breast Cancer Chemotherapy: EC vs. Docetaxel Contrasting Immune Effects of Breast Cancer Chemotherapy: EC vs. Docetaxel...
Male Breast Cancer: Rare but Underdiagnosed with Poorer Prognosis Male Breast Cancer: Rare but Underdiagnosed with Poorer Prognosis Male breast...
Scientists Uncover Mechanism of Breast Cancer Metastasis Scientists Uncover Mechanism of Breast Cancer Metastasis New research has revealed the crucial...
Parkinson's Drug Found Effective Against Brain Metastasis in Breast Cancer Parkinson's Drug Found Effective Against Brain Metastasis in Breast Cancer...
Does Milk Really Cause Breast Cancer and Promote Tumor Grow? Does Milk Really Cause Breast Cancer and Promote Tumor Grow?...
Harvard Scientists Confirm Low Air Pollution Levels Pose Cancer Threat Harvard Scientists Confirm Low Air Pollution Levels Pose Cancer Threat...
The Rising Awareness of Male Breast Cancer The Rising Awareness of Male Breast Cancer Five years ago, a Florida man...
Tumor Tissue Spatial Structure Determines Immunotherapy Efficacy Tumor Tissue Spatial Structure Determines Immunotherapy Efficacy While immunotherapy has already found application...
Luminal A Breast Cancer Patients May Not Require Radiotherapy After Breast-Conserving Surgery NEJM: Luminal A Breast Cancer Patients May...
New Genetic Factors for Breast Cancer through Genome Study New Genetic Factors for Breast Cancer through Genome Study. A...
New clinical classification and treatment strategies of HER2-positive breast cancer Interpretation of the review: New clinical classification and treatment...
Breast cancer patients may have chromosomal mutations as early as 6 years old Breast cancer patients may have chromosomal...
